Coherent Market Insights (Healthcare, Biotechnology, Medical Devices, Pharmaceutical)

Friday, October 5, 2018

Cast Removal Device Market Revenue Opportunities By Key Vendors DeSoutter medical, Erbrich Instrumente GmbH, Ermis MedTech, Hanshin Medical Co.,ltd, HEBUmedical GmbH

Cast Removal Devices are designed to cut cast material such as fiberglass, plastic or plaster and bandage that are used for rehabilitation of the fractured bones or ruptured tendons. It is mainly used by orthopedic surgeons in hospitals and clinics to cure musculoskeletal injuries caused due to road accidents and during sports practices. According to the U.S. Department of Health & Human Services report on January 2018, road traffic injuries are a huge economic burden on low and middle income economies and are estimated to cost US$ 518 billion globally. In many areas in the emerging economies, technology has still not found there roots to grow and people use home remedies such as securing with wooden sticks instead of casting plaster.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1493

The development of hospital facilities in these areas will drive growth of cast removal device market. In November 2016, Stryker Corporation, one of the world's leading medical technology company, announced a multi-year collaboration with Indo UK Institute of Health's (IUIH) Medicity Program to serve greater access to affordable services to patients in India, which will also help in propelling growth of cast removal device market.

Cast Removal Device Market Driver:

Increase in frequency of road accidents and musculoskeletal injuries during sports is expected to drive growth of the cast removal devices market. According to a survey published by the World Health Organization (WHO) in Jan, 2018, over 3,400 people die on the world's roads every day and tens of millions of people are injured or disabled every year. Also, according to the John Hopkin’s Medicine, in the U.S., over 3.5 million children at the age of 14 and younger get hurt annually by playing sports or participating in recreational activities.

The upcoming 2030 Agenda for Sustainable Development adopted by world leaders aims at halving the global number of deaths and injuries from road traffic crashes by 2020. Moreover, from 2015-2019, the World Health Organization is collaborating with the Bloomberg Initiative for Global Road Safety (BIGRS) to reduce fatalities and injuries from road traffic crashes. Such forthcoming schemes of the governmental organizations will hinder growth of cast removal devices market, whereas people neglecting traffic rules or distracted driving because of alcohol and other abuse, unsafe road infrastructure, below mark vehicle quality, and many others factors are expected to propel the cast removal device market growth.

Cast Removal Devices Market – Competitors

The major players operating in the cast removal devices market include DeSoutter medical, Erbrich Instrumente GmbH, Ermis MedTech, Hanshin Medical Co.,ltd, HEBUmedical GmbH, Osimed medical, Rimec S.R.L., Shanghai Bojin Medical instrument Co., Ltd., Stryker, and TREU-Instrumente GmbH.

Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1493

Cast Removal Device Market Taxonomy:

By Product Type:

Vacuum cutter
Saw cutter
Cast spreader

By Energy Source:

Battery powered (cordless)
Electric (corded)

By End Users:

Clinics
Hospitals
Rehabilitation centers
Other

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Thursday, September 27, 2018

Hot and Cold Therapy Packs Various Aesthetic Benefits to Give Rise to Industry during Forecast Period 2018-2026

Heat and cold therapy is a non-invasive and non-addictive pain relief therapy used for muscle relaxation, improving blood circulation, and reducing swelling. Heat and cold therapy is the most effective, inexpensive, and rapid relief treatment therapy. Different types of injuries cause swelling and inflammation, for which application of ice decreases the blood flow towards injury thereby, reducing the swelling and inflammation. However, heat therapy aids in increasing blood flow in turn supplying nutrients and oxygen in order to relax the ligaments and muscle. Heat is applied by electric or microwave heating pads, hot water bath or gel packs. Whereas, cold therapy is consists of ice or cold gel packs. Heat and cold therapy are good for strains, sprains, and bruises that occur during heavy physical or sports training sessions.

Increasing adoption of non-surgical and non-pharmaceutical pain relive management therapies is expected to boost growth of the hot and cold therapy packs market.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1133

According to World Health Organization (WHO) 2015, approximately 8 million individuals face minor accidents, every day. Thus, minimal injuries due to accidents and its treatments to relieve the pain are factors expected to fuel the hot and cold therapy packs market growth. Moreover, according to the Arthritis Foundation, cold packs are best for severe pain in body parts whereas, heat treatment such as warm baths and heating pads are likely to aid in relaxing stiff joints and muscles.

Enhanced access to healthcare services such as easy availability of pain and injury relief therapies and increased personal health care spending are factors anticipated to boost the hot and cold therapy packs market growth. Moreover, market is witnessing growth due to increasing inclination of the populace towards non-surgical pain solutions and wound management for pain relief. For instance, according to a study conducted by University of Leiden in 2015, majority of surgeons recommended non-surgical treatments such as physical therapy or acetaminophen therapy for the treatment of osteoarthritis. Moreover, geriatric population suffering from chronic illness such as osteoporosis and arthritis prefer home care such as hot and cold therapy packs instead of frequently visiting hospitals or consuming drugs. The use of hot and cold therapy packs is safer and easy as compared to drugs and physiotherapy treatment. Thus, increasing non-pharmacological cure treatment for pain relive especially in geriatric population is a driving factor for growth of the market. However, increasing adoption of herbal and reusable packs for pain relief are factors expected to hinder the market growth.

Hot and Cold Therapy Packs Market: Competitive Key Vendors

Major key players in the global hot and cold therapy packs markets include 3M, Caldera International Inc., Cardinal Health, Chattanooga Group Inc., Halyard Health, Inc., Beiersdorf Australia Ltd., Breg, Inc., Corso Enterprises, Inc., Covidien plc., Core Products International, Inc., DJO Global, Inc., Kobayashi Pharmaceutical Co., Ltd., Medline Industries, Inc., Bruder Healthcare Company, Inc., Thermionics Corp., and Carex Health Brands.

Market Taxonomy:

The global hot and cold therapy packs market is segmented on the basis of product type, application type, distribution channel, and geography.

On the basis of product type, the global hot and cold therapy packs market is segmented into:

Therapy pads
Gel Packs
Instant Packs
Bottle System
Patch
Wraps
Others

On the basis of application type, the global hot and cold therapy packs market is segmented into:

Accident
Injury
Mastitis
Pain management
Others

On the basis of distribution channel, the global hot and cold therapy packs market is segmented into:

Hospital pharmacies
Online pharmacies
Retail pharmacies

Geographically, the global hot and cold therapy packs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Mannequin-Based Simulation Market - Substantial Rise in Industrial Sectors to Offer Growth Prospects by 2026

Mannequins are replica or dummy models used as virtual patients in the hospital and medical education. Mannequin is a technique for medical simulation, which aims to train medical specialist and professionals to reduce the risk of adverse accidents during general practice, treatment, and surgery. Mannequin-based simulators are common objects in fields such as operation room, ICUs, delivery room, emergency departments, and research academies. Mannequin simulators are used for the purpose of learning and experience in multidisciplinary areas. The simulation activity provides expertise in medical and healthcare sector without any risk of patient’s life. Moreover, apart from medical and hospital organizations they are used in military administration through which the military forces can get expertise to act in hostilities and combat zone.

Affordability and rising implementation of simulation significantly bolstering the market.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1135

The perception of using replica model is to acquire the medical expertise is on the demand as the simulation technique model is affordable and easy to practice medical procedure instead of directly applying on the patient which might become life-threatening to a patient. Increasing demand for minimally invasive treatment and rising focus on patient’s safety are the factors driving the market growth. Moreover, rising implementation of simulation technology is another factor anticipated to drive the market growth. For instance, according to a report on the U.S. medical schools curricula by the Association of American Medical Colleges in 2014, 136 out of 140 medical schools participated in the survey had simulation centers in which mannequin based simulation was one of the most commonly practiced type of healthcare education provided to the medical students. These models are also used in military organizations to provide soldiers skillfulness to act in the war zone. Hence, the high need and acceptance of simulation in army and medical administration correspondingly is fueling the growth of mannequin-based simulation market. However, limited availability of funds provided by government as well as simulation promoters to produce number of mannequin model is the major factor hampering the market growth.

Minimally invasive treatment procedures and increasing demand for patient care marking North America and Europe as dominating regions for the mannequin-based simulation market.

Mannequin-Based Simulation Market: Competitive Key Players

The key players operating the global mannequin-based simulation market are 3D systems, Kyoto Kagaku Co., Ltd., Laerdal Medical A/S, Simbionix Corporation, Limbs & Things Ltd., CAE Healthcare, Gaumard Scientific Company, Inc., Simulab Corporation, Mentice AB, and Simulaids, Inc.

Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1135

Market Taxonomy:

The global mannequin-based simulation market is segmented on the basis of product type, application type, end user, and geography.

On the basis of product type, the global mannequin-based simulation market is segmented into:

Patient Simulators
Surgical Simulators
Dental and Eye Simulators
Endovascular Simulators
Ultrasound Simulators
Task Trainers

On the basis of end-user, the global mannequin-based simulation market is segmented into:

Hospitals
Military organizations

On the basis of region, the global mannequin-based simulation market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Orthopedic Power Tools Market - Industry Analysis, Size, Share, Trends, Demand, Overview, Forecast 2025

Orthopedics is the branch of surgery concerned with conditions involving the musculoskeletal system. The branch is characterized by both surgical and nonsurgical means to treat musculoskeletal trauma, spine diseases, sports injuries, degenerative diseases, infections, tumors, and congenital disorders. Procedures such as dissection, fixation, shaping, cutting, and fragmentation in orthopedic procedures are performed with the help of instruments and accessories powered with electricity. Moreover, several of these tools are pneumatic that are powered using nitrogen or compressed air. Pneumatic-powered tools are easy to handle as they are small, vibration free, and light in weight.

Orthopedic power tools facilitate accuracy and speed while performing orthopedic surgeries. Light-weight, highly modular, easy-to-assemble, and user friendly orthopedic power tools are easier to handle as compared to conventional heavy tools. Such properties of orthopedic power tools are contributing to positive growth of the orthopedic power tools market.

Global orthopedic power tools market growth is driven by advancements in technology and rise in orthopedic surgeries.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1161

The global orthopedic power tools market was valued at US$ 829.63 million in 2016 and is expected to exhibit a robust CAGR of 3.3% over the forecast period (2017–2025).

Powered orthopedic instruments are utilized in knee, shoulder, wrist and joint replacement surgeries, and other orthopedic procedures. The accessories used in such procedures use three power sources, which include electric powered devices that are operated through electrical supply (wall mount); battery powered devices, which use lithium ion batteries; and pneumatic powered devices that are operated through air pressure generated through an air reservoir attached to the device.

Market Dynamics

Major factors responsible for growth of orthopedics power tools market include increasing number of orthopedic surgeries coupled with shortage of skilled and trained surgeons. According to Becker’s Ambulatory Surgical Centre Review, in 2011, total of 5.3 million orthopedic surgeries were performed and this number was projected to rise to 6.6 million by 2020. This high prevalence rate is expected to fuel demand for orthopedic power tools for orthopedic surgical procedures in the near future.

Other factors such as new product launches and advancement in technology in these devices is also contributing to the market growth. For instance, in March 2017, Stryker Corporation introduced range of instruments under brand name System 8 Power Tool. The tool has advanced System 8 SABO sagittal saw and System 8 cordless drivers for better accuracy and efficiency.

However, contamination in the reusable devices, pricing pressure on manufacturers, and unfavorable reimbursement scenario are expected to restrain the market growth. For instance, according to CDC in 2011, the prevalence of healthcare associated infection were estimated at 157,500 surgical site infections in inpatient surgeries.

Orthopedic Power Tools Market: Competitive Key Vendors

Global players in the industry are partnering with companies and organization based in Asia, in order to expand their geographic presence in this highly lucrative market. This is expected to increase the availability of advanced equipment such as orthopedic power tools in the region. For instance, Stryker Corporation entered into a multi-year partnership with Indo-UK Institute of Health in November 2016, to deliver affordable orthopedic instruments in India.

Key players operating in the global orthopedic power tools market include Stryker Inc., Zimmer Holdings Inc., Misonix Inc., Arthrex, Aesculap, ConMed Corporation, DePuy Synthes, Brasseler, Medtronic, MedicMicro, B. Braun, OsteoMed, and Aygun Surgical Instruments.

Key features of the study:

This report provides an in-depth analysis of global orthopedics power tools market provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year.
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players.
It profiles leading players in the global orthopedic power tools market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
Key companies covered as a part of this study include Stryker Inc., Zimmer Holdings Inc., Misonix Inc., Arthrex, Aesculap, ConMed Corporation, DePuy Synthes, Brasseler, Medtronic, MedicMicro, B. Braun, OsteoMed, and Aygun Surgical Instruments.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
The global orthopedic power tools market report caters to various stakeholders in this industry including investors, suppliers, product/device manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the orthopedic power tools market

Sepsis Diagnostic Market Analysis, Guidelines Overview and Upcoming Trends Forecast till 2026

Sepsis is life threatening complication caused due to the infection, which can result into organ failure, tissue damage, and ultimately lead to death if left untreated. If sepsis progresses to septic shock, it cause sudden drop in blood pressure and may leads to death of patient. Sepsis occurs due the infection in any part of the body. However the most common site of infections leading to the sepsis are lungs, abdomen, pelvis, and urinary tract.

Patients suffering from impaired immune system due to illness or drugs, cancer treatment with chemotherapy, splenectomy, sickle cell disease, and people who consume steroids and immunosuppressant drugs are prone to sepsis. The symptoms associated with sepsis includes high fever with temperature above 101⁰ F or temperature below 96.8 F, increased heart rate to 90 beats per minute, high breathing rate to around 20 breaths per minute, tissue swelling and confirmed infection. According to the Healthcare Cost and Utilization Project (HCUP) report submitted by Agency for Healthcare Research and Quality (AHRQ) in 2016, septicemia accounted for the leading cause of hospitalization in the U.S., owing to consuming more than US$ 24 billion each year.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1166

Increasing prevalence of sepsis is resulting into high demand for sepsis diagnostic devices in the market. According to the Sepsis Alliance report 2016, sepsis affects over 26 million people worldwide and more than 5 million children each year. According to the Centers for Disease Control and Prevention (CDC), more than 1.5 million people in the U.S. suffer from sepsis annually and around 2,50,000 Americans die each year due to sepsis.

The treatment for sepsis varies depending upon the site and cause of infections. Early symptoms of sepsis can be treated by visiting hospitals for diagnosis and treatment. However, severe sepsis and sepsis shock are medical emergencies, which need quick medical attention. The treatment includes rapid administration of antibiotic and intravenous fluid (IV fluid) to the patient detected with symptoms of sepsis, as the risk of death form sepsis increases by 7.6% with every hour from the time of treatment begins. Antibiotic treatment mainly includes broad spectrum antibiotic given by intravenous. The antibiotics used in the sepsis treatment includes vancomycin, piperacillin, tazobactam, cefepime, tobramycin, and aztreonam.

Recent advances in Sepsis Diagnostic Market

F.Hoffmann-La Roche in June 2016 receives the FDA clearance for its Procalcitonin (PCT) assay, which helps clinicians to effectively assist sepsis risk and manage sepsis patients. The assay provides the testing solution for people with severe sepsis or septic shock. Roche is the first company from U.S. to provide fully integrated solution for sepsis risk assessment and management.

Singulex, Inc. an immunodiagnostic company engaged in developing single molecule counting (SMC) technology for clinical diagnosis and scientific research, in December 2016 signed a license and supply agreement with Thermo Fisher Scientific Inc. The agreement allows Singulex access to Thermo Fisher’s BRAHMS PCT biomarker, which is used to diagnose systemic bacterial infection and treatment of sepsis in Europe.

Key players in the sepsis diagnostic market:

Some of the key players operating in the sepsis diagnostic market includes BioMerieux SA, Cepheid, Thermo Fisher Scientific Inc., T2 Biosystems, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche Ltd, Luminex Corporation, Becton, Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.

Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1166=

Sepsis Diagnostic Market Taxonomy:

On the basis of product, sepsis diagnostic market segmented into:

Assay and reagents
Blood culture media
Instruments
Others

On the basis of pathogen, sepsis diagnostic market segmented into:

Fungal sepsis
Bacterial sepsis

Gram-positive bacterial sepsis
Gram-negative bacterial sepsis

Other infectious pathogens

On the basis of methods, sepsis diagnostic market segmented into:

Immunoassays
Flow cytometry
Molecular diagnosis
Biomarker diagnosis

On the basis of diagnostic method, sepsis diagnostic market segmented into:

Conventional diagnostic methods
Automated diagnostic methods

On the basis of end user, sepsis diagnostic market segmented into:

Hospital laboratories
Diagnostic & Pathology laboratories
Academic and research laboratories
Other end users

Urinary Tract Infection Market Development Status, Size, Share, Growth and Forecast Report To 2026

Urinary Tract Infection (UTI) is caused when bacteria enters the urethra and infects the urinary bladder, causing severe health issues. UTI infections are common health problems in females than in males with biologic factors accounting as the major cause. Antibiotics are usually the first line of treatment prescribed by doctors for urinary tract infections. According to the site of manifestation by the microbe, infections are classified as cystitis (bladder), urethritis (urethra), prostatitis (prostate) or pyelonephritis (kidney). Painful and increased frequency of urination, excessive and involuntary passing of urine at night are the common symptoms associated with UTI. Hospitalized patients using urinary catheters are at a higher risk for developing UTI.

Increasing prevalence of recurring urinary infections is expected to boost growth of the urinary tract infection treatment market.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1178

Rise in chronic kidney diseases and increasing use of urinary catheterization is leading to development of urinary infections and this is expected to be major growth drivers for urinary tract infection market. According to the Centers of Disease Control and Prevention, 2016, UTIs are the most common bacterial infections globally, affecting 150 million people every year. Furthermore, about 10 in 25 women and 3 in 25 men are estimated to have symptoms of at least one UTI during their lifetime. According to the study by Sultan Qaboos University Medical Journal, 2013, around 50–60% of women report at least one UTI in their lifetime, and one in three will have at least one symptomatic UTI necessitating antibiotic treatment by age 24. Also, patients with diabetes have a higher frequency of UTIs, due to the presence of long-term complications of diabetes such as neuropathy. According to the American Diabetes Association, in 2017, 9.4% of the people diagnosed with type 2 diabetes had a UTI compared to only 5.7% of people without diabetes.

Approval of combination products for improving indications of existing drugs and to combat multi-drug resistant bacteria are some key factors positively affecting market growth. For instance, in 2015, FDA approved Avycaz (ceftazidime and avibactam) for complicated abdominal and urinary tract infections in combination with metronidazole that has limited or no alternative treatment options.

Strategic collaborations is the strategy adopted by key players in the market to enhance its presence and for new drug development.

Strategy of leading players is to achieve growth through mergers & acquisitions and collaborations. In 2016, GlaxoSmithKline and Fimbrion Therapeutics, Inc., entered into a collaboration, which is focused on preclinical development of mannose-containing small molecule compounds called mannosides for the treatment and prevention of urinary tract infections.

Key players operating in the urinary tract infection treatment market include Cipla Ltd., Johnson & Johnson, Bayer AG, Pfizer Inc., GlaxoSmithKline, Boehringer Ingelheim, F. Hoffmann-La Roche Ltd., Novartis AG AstraZeneca Plc, and Roche Ltd.

Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1178

Market Taxonomy:

The global urinary tract infection treatment market is segmented on the basis of drug type, indications, distribution channel, and geography.

On the basis of drug type, the global urinary tract infection treatment market is segmented into:

Nitrofurans
Sulphonamides
Quinolones
Azoles and Amphotericin B
Aminoglycoside antibiotics
Tetracycline
Others

On the basis of indication, the global urinary tract infection treatment market is segmented into:

Complicated UTI
Uncomplicated UTI
Recurring Complicated UTI

On the basis of distribution channel, the global urinary tract infection market is segmented into:

Hospital Pharmacies
e-Pharmacies
Retail Pharmacies

Rising catheter associated urinary infections is expected to fuel growth of the urinary tract infection treatment market in North America.

Cataract Surgery Devices Market 2018 Analysis by Growth, Major Manufacturers, Competitive Strategies and Forecast to 2026

Cataract surgery devices are used during the surgical procedures to treat cataract, which is an eye disorder that causes clouding of the lens leading to defects in vision. Cataract is one of the most widespread disease causing blindness and it reduces vision ability. Cataract is often encountered to develop slowly and affect either one or both the eyes.

Although cataract does not interfere with the eyesight in the early stages, it interferes with vision and may lead to blindness over the course of time. The symptoms of cataract include blurry vision, trouble with bright lights, faded colors, and trouble seeing in the night. Cataract surgery is the most commonly performed ophthalmic procedure and thus holds a great potential for the growth of cataract surgery devices market.

Cataract encountered to be the major cause of blindness across the globe facilitating the demand for cataract surgery devices.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1197

According to the American Academy of Ophthalmology, over 24.4 million Americans of age 40 years and above were affected with cataract in 2014. The same report states that by the age of 75 years, almost half of the Americans have cataracts. According to the International Agency for the Prevention of Blindness (IAPB), approximately 285 million people are visually impaired worldwide out of which around 39 million are blind and about 246 million are suffering with low vision. The report suggests that cataract and glaucoma are the prime causes of blindness across the globe in 2015. However, 4 out of 5 blind or visually impaired cases are avoidable according to the Global Facts: Blindness and Visual Impairment. Increasing cataract surgeries are fueling the growth of global cataract surgery devices market.

Product innovation and evolution by new entrants in the pool to propel cataract surgery devices market growth.

The key players operating in the global cataract surgery devices market include Abbott Laboratories, Carl Zeiss Meditech AG, Bausch & Lomb, Inc., Allergen, Inc., Alcon, Inc., Opcon Corporation, Essilor International S.A., STAAR Surgical Company, and NIDEK Co., Ltd. Various emerging players are also coming up with innovative products in the market to establish their presence and generate significant revenue with their innovative ideas. For instance, in March 2016, Mynosys Cellular Devices, Inc., a private company invented a unique cataract surgery device named Zepto that features a small control console and a disposable hand-piece that provides high precision, accuracy, and safety in reproducible capsulotomy.

Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1197

Global Cataract Surgery Devices Market Taxonomy:

On the basis of product type, the global cataract surgery devices market is segmented into:

Intraocular Lens (IOL)
Ophthalmic Viscoelastic Device (OVD)
Phacoemulsification Equipment
Femtosecond Laser Equipment

On the basis of end user, the global cataract surgery devices market is segmented into:

Hospitals
Clinics
Ophthalmology Centers

Substantial number of cataract surgeries are dominating the North America global cataract surgery devices market.